U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
APX 003
Preferred Name English
Suvemcitug
INN  
Official Name English
Sevacizumab [WHO-DD]
Common Name English
APX-003
Code English
immunoglobulin G1-kappa, anti-[Homo sapiens VEGFA (vascular endothelial growth factor A, VEGF-A, VEGF)], humanized monoclonal antibody (gamma1 heavy chain humanized (1-452) [VH (Homo sapiens IGHV3-21*01 (74.7%) -(IGHD) -IGHJ2*01 (92.9%), CDR-IMGT [9.8.14
Common Name English
suvemcitug [INN]
Common Name English
BD-0801
Code English
Sevacizumab
Common Name English
Immunoglobulin G1, anti-(human vascular endothelial growth factor) (human-Oryctolagus cuniculus monoclonal APX 003 ?1-chain), disulfide with human-Oryctolagus cuniculus monoclonal APX 003 ?-chain, dimer
Common Name English
Code System Code Type Description
FDA UNII
T7Y5VC4ERJ
Created by admin on Wed Apr 02 17:05:45 GMT 2025 , Edited by admin on Wed Apr 02 17:05:45 GMT 2025
PRIMARY
SMS_ID
300000050050
Created by admin on Wed Apr 02 17:05:45 GMT 2025 , Edited by admin on Wed Apr 02 17:05:45 GMT 2025
PRIMARY
NCI_THESAURUS
C122403
Created by admin on Wed Apr 02 17:05:45 GMT 2025 , Edited by admin on Wed Apr 02 17:05:45 GMT 2025
PRIMARY
INN
12428
Created by admin on Wed Apr 02 17:05:45 GMT 2025 , Edited by admin on Wed Apr 02 17:05:45 GMT 2025
PRIMARY
CAS
1610010-57-5
Created by admin on Wed Apr 02 17:05:45 GMT 2025 , Edited by admin on Wed Apr 02 17:05:45 GMT 2025
PRIMARY
ACTIVE MOIETY
Suvemcitug
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966